University of Erlangen-Nürnberg Medical School
fau.deTotal trials
269
Active
46
Phase 3
43
Total enrollment
55,374
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Dapagliflozin 10mg Tab | — | — | — | — | — | 1 | |
| Three intra-articular hyaluronic acid (HA) injections | — | — | — | — | — | 1 | |
| One intra-articular hyaluronic acid (HA) | — | — | — | — | — | 1 | |
| Chemotherapy 5-Fluorouracil | — | — | — | — | — | 1 | |
| Chemotherapy Cisplatin | — | — | — | — | — | 1 | |
| Additional interventional telemedical management | — | — | — | — | — | 1 | |
| Cisplatin | — | — | — | — | — | 1 |
Next readouts
- 2026-04-30
- 2026-08-01
- 2026-10-31
- 2094-12-31
- 2098-12-31
Top conditions
- Ulcerative Colitis10
- Hypertension10
- Metabolic Syndrome7
- Cancer7
- Inflammatory Bowel Diseases6
- Rheumatoid Arthritis5
- Osteopenia5
- Crohn's Disease5
Frequently asked questions about University of Erlangen-Nürnberg Medical School
- How many clinical trials does University of Erlangen-Nürnberg Medical School have on ClinicalTrials.gov?
- University of Erlangen-Nürnberg Medical School is listed as the lead sponsor on 269 clinical trials in ClinicalTrials.gov, 46 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Erlangen-Nürnberg Medical School's trials are in Phase 3?
- 43 of University of Erlangen-Nürnberg Medical School's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does University of Erlangen-Nürnberg Medical School focus on?
- University of Erlangen-Nürnberg Medical School's most-studied conditions on ClinicalTrials.gov are Ulcerative Colitis, Hypertension, Metabolic Syndrome, Cancer, Inflammatory Bowel Diseases.
- When are University of Erlangen-Nürnberg Medical School's next clinical trial readouts?
- University of Erlangen-Nürnberg Medical School has 5 upcoming primary-completion readouts tracked here; the soonest is “The smartNTx Trial:Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (KTR)”, expected around 2026-04-30.